US Patent

US11690853 — Non-hormonal steroid modulators of NF-ÎºÎ² for treatment of disease

Method of Use · Assigned to Reveragen Biopharma Inc · Expires 2033-03-07 · 7y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects non-hormonal steroid modulators of NF-ÎºÎ² for use in treating diseases.

USPTO Abstract

The present invention relates to compounds and methods which may be useful as treatments of diseases.

Drugs covered by this patent

Agamree (VAMOROLONE) · Catalyst Pharms

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3747`	—	Agamree

Patent Metadata

Patent number: US11690853
Jurisdiction: US
Classification: Method of Use
Expires: 2033-03-07
Drug substance claim: No
Drug product claim: No
Assignee: Reveragen Biopharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.